Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated May 13, 2016. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2016. Go to the latest filing (Q3 2026)

6.9B USDQ1 2016
Total value of stock positions
6.9B USD
Positions
33
Share of the ten largest
80.6%

The ten largest positions Q1 2016

  1. E M C Corp Mass 20.1%▲ +77.3%
  2. Cheniere Energy Inc 14.7%▲ +14.4%
  3. Viasat Inc 12.3%unchanged
  4. Antero Res Corp 7.8%▲ +12.2%
  5. Allergan PLC 6.7%new
  6. Pbf Energy Inc 5.1%▼ −3.5%
  7. PayPal 4.0%▼ −36.5%
  8. Innoviva Inc 3.6%new
  9. Twenty First Centy Fox Inc 3.1%▲ +87.8%
  10. Twenty First Centy Fox Inc 3.0%▲ +11.5%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q1 2016

Positions Q1 2016 per 13F filing, 33 of 33
Symbol Weight Shares Reported value Change Held since
E M C Corp Mass 20.1% 51,851,500 1.4B USD +77.3% increased Q4 2015 2 quarters
Cheniere Energy Inc 14.7% 29,841,174 1.0B USD +14.4% increased Q1 2014 9 quarters
Viasat Inc 12.3% 11,533,137 847.5M USD unchanged Q2 2013 or earlier 12 quarters
Antero Res Corp 7.8% 21,505,881 534.9M USD +12.2% increased Q3 2014 7 quarters
Allergan PLC 6.7% 1,721,587 461.4M USD new Q1 2016 1 quarter
Pbf Energy Inc 5.1% 10,641,175 353.3M USD −3.5% reduced Q3 2013 11 quarters
PYPL PayPal 4.0% 7,059,745 272.5M USD −36.5% reduced Q3 2015 3 quarters
Innoviva Inc 3.6% 19,815,983 249.5M USD new Q1 2016 1 quarter
Twenty First Centy Fox Inc 3.1% 7,696,922 214.6M USD +87.8% increased Q3 2015 3 quarters
Twenty First Centy Fox Inc 3.0% 7,278,100 205.2M USD +11.5% increased Q3 2015 3 quarters
Olin Corp 2.7% 10,739,202 186.5M USD +53.4% increased Q3 2015 3 quarters
Theravance Biopharma Inc 1.8% 6,500,991 122.2M USD +1.3% increased Q2 2014 8 quarters
Keryx Biopharmaceuticals Inc 1.8% 25,791,678 120.4M USD unchanged Q1 2014 9 quarters
Vmware Inc 1.7% 2,252,694 117.8M USD new Q1 2016 1 quarter
Veritiv Corp 1.7% 3,044,385 113.4M USD +5.5% increased Q3 2014 7 quarters
Atara Biotherapeutics Inc 1.5% 5,359,632 102.0M USD unchanged Q4 2014 6 quarters
Forward Pharma A/S 1.3% 5,367,300 91.2M USD unchanged Q4 2014 6 quarters
Novagold Res Inc 1.1% 15,000,000 75.6M USD −21.0% reduced Q2 2013 or earlier 12 quarters
Chipmos Tech Bermuda Ltd 0.9% 3,751,853 65.2M USD unchanged Q2 2013 or earlier 12 quarters
Klx Inc 0.9% 2,000,000 64.3M USD unchanged Q1 2015 5 quarters
Sunedison Semiconductor Ltd 0.8% 8,372,979 54.3M USD unchanged Q2 2014 8 quarters
American Intl Group Inc 0.6% 2,124,551 39.7M USD +68.8% increased Q2 2013 or earlier 12 quarters
Silver Run Acquisition Corp 0.6% 3,750,000 38.8M USD new Q1 2016 1 quarter
Biotie Therapies Oyj 0.5% 1,395,000 36.8M USD unchanged Q2 2015 4 quarters
Paratek Pharmaceuticals Inc 0.3% 1,544,498 23.4M USD unchanged Q4 2014 6 quarters
RUN Sunrun 0.3% 2,848,082 18.5M USD unchanged Q3 2015 3 quarters
La Quinta HLDGS Inc 0.2% 1,111,000 13.9M USD new Q1 2016 1 quarter
Orexigen Therapeutics Inc 0.2% 22,268,399 12.5M USD +881.7% increased Q3 2015 3 quarters
Kindred Biosciences Inc 0.2% 3,013,848 10.4M USD unchanged Q4 2013 10 quarters
Citigroup Inc 0.1% 102,553,207 10.3M USD unchanged Q2 2013 or earlier 12 quarters
Bellatrix Exploration Ltd 0.1% 8,653,281 8.7M USD −63.9% reduced Q4 2014 6 quarters
Genworth Finl Inc < 0.1% 1,699,195 4.6M USD new Q1 2016 1 quarter
Novacopper Inc < 0.1% 10,600,758 4.0M USD unchanged Q2 2013 or earlier 12 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 3 positions in convertible bonds and bonds worth 59.8M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Inc principal 48.2M USD 37.8M USD
  • Chesapeake Energy Corp principal 23.3M USD 14.7M USD
  • Chesapeake Energy Corp principal 11.5M USD 7.3M USD

Breakdown by sector

  • Financials 4.0%
  • Industrials 0.3%
  • not in our coverage 95.8%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close